Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 12,678,708 shares, a decline of 24.0% from the October 13th total of 16,684,474 shares. Based on an average daily volume of 3,262,468 shares, the days-to-cover ratio is currently 3.9 days. Currently, 15.0% of the shares of the stock are short sold.

In related news, CEO Joey A. Jacobs sold 500,000 shares of the company’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the transaction, the chief executive officer now directly owns 201,496 shares in the company, valued at $10,213,832.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ronald Morgan Fincher sold 80,000 shares of the company’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $4,055,200.00. Following the completion of the transaction, the chief operating officer now owns 59,071 shares of the company’s stock, valued at $2,994,308.99. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,824,040 shares of company stock valued at $92,460,588. 11.10% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Acadia Healthcare by 11.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after purchasing an additional 270 shares in the last quarter. C M Bidwell & Associates Ltd. bought a new stake in shares of Acadia Healthcare during the 2nd quarter worth $205,000. Riverhead Capital Management LLC bought a new stake in shares of Acadia Healthcare during the 2nd quarter worth $209,000. Rathbone Brothers plc bought a new stake in shares of Acadia Healthcare during the 3rd quarter worth $223,000. Finally, World Asset Management Inc bought a new stake in shares of Acadia Healthcare during the 2nd quarter worth $242,000.

Acadia Healthcare (ACHC) opened at $28.23 on Friday. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $2,515.25, a price-to-earnings ratio of 12.50, a price-to-earnings-growth ratio of 1.06 and a beta of 0.89. Acadia Healthcare has a one year low of $27.88 and a one year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). The firm had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.58 earnings per share. equities research analysts predict that Acadia Healthcare will post 2.23 earnings per share for the current year.

ACHC has been the subject of several analyst reports. William Blair initiated coverage on Acadia Healthcare in a research report on Tuesday, July 18th. They issued an “outperform” rating for the company. BMO Capital Markets assumed coverage on Acadia Healthcare in a research note on Monday, October 16th. They set an “outperform” rating and a $52.00 price objective on the stock. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, October 12th. Mizuho set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a report on Tuesday, October 24th. Finally, Jefferies Group LLC set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $45.15.

ILLEGAL ACTIVITY NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Short Interest Down 24.0% in October” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2017/11/12/acadia-healthcare-company-inc-achc-short-interest-down-24-0-in-october.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.